Utang jangka cendhak perusahaan: Applied DNA Sciences Inc (APDN)

Logo perusahaan publik Applied DNA Sciences (APDN)

Applied DNA Sciences (APDN) management is effectively allocating resources between biotechnology and cargo security, as confirmed by the stock quotes on this chart, where the indicator stands at 0.00. The business relies on a flexible molecular tagging system available to various industries at low cost. The current development vector is based on increasing the number of B2B deals for the supply of reagents for medical research and DNA synthesis.

APDN Kewajiban jangka cendhak Applied DNA Sciences, Inc. (04.07.2022 - 07.10.2025)
Produk sing diprodhuksi Applied DNA Corp

Uninterrupted supplies of synthetic DNA components require precise working capital management, which directly impacts current liability levels. This indicator measures the aggregate of obligations maturing within twelve months, allowing for an assessment of liquidity and default risk through the analysis of short-term credit obligations. Monitoring this metric protects the assets of Applied DNA Sciences (APDN) from excessive debt pressure, ensuring the business's financial stability.

Pesaing langsung

Tempus AI, Inc - Utang jangka cendhak perusahaan|QGEN - Utang jangka cendhak perusahaan|Ionis Pharma (IONS) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak RGEN (Repligen Inc.)|Utang jangka cendhak perusahaan Avidity Biosciences|crisprtx.com - Kewajiban jangka cendhak|Utang jangka cendhak perusahaan GeneDx (WGS)|Utang jangka cendhak perusahaan RARE (Ultragenyx Pharmaceutical Inc.)|Utang jangka cendhak perusahaan BEAM (Beam Therapeutics Corp)|Gunggunge utang jangka cendhak Sarepta Corp (SRPT)|Twist Bioscience - Utang jangka cendhak perusahaan|Utang jangka cendhak 10xgenomics.com|NTLA: Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan STOK|Kewajiban jangka cendhak perusahaan BLFS|WVE: Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan MAZE|sionnatx.com - Tanggungan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Prime Medicine PRME|TSHA: Tanggungan utang jangka cendhak perusahaan|uniQure Corp - Utang jangka cendhak perusahaan|MGTX - Utang jangka cendhak perusahaan|RGNX (REGENXBIO Inc.) - Kewajiban jangka cendhak perusahaan|solidbio.com - Silihan lan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan Ocugen|Pacific Biosciences of California, Inc. (PACB) - Gunggunge utang jangka cendhak|Utang jangka cendhak perusahaan BNTC|Kewajiban jangka cendhak perusahaan Design Corp DSGN|Utang jangka cendhak perusahaan RCKT (Rocket Pharmaceuticals)|Gunggunge utang jangka cendhak 4dmoleculartherapeutics.com (FDMT)|Lexeo - Utang jangka cendhak perusahaan|Utang jangka cendhak Korro Bio, Inc.|Editas (EDIT) - Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan SLN|PRQR (ProQR) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak perusahaan Codexis Bio (CDXS)|Utang jangka cendhak perusahaan SGMO|NAUT - Utang jangka cendhak|Utang jangka cendhak perusahaan Metagenomi, Inc MGX|Gunggunge utang jangka cendhak precisionbiosciences.com (DTIL)|Generation Bio Corp - Utang jangka cendhak perusahaan|BOLD - Utang jangka cendhak perusahaan|exicuretx.com (XCUR) - Utang jangka cendhak perusahaan|Kewajiban jangka cendhak IMNN (Imunon)|PHIO (Phio Pharmaceuticals Corp) - Utang jangka cendhak perusahaan|Tanggungan utang jangka cendhak perusahaan MBIO (Mustang Bio Corp)|Utang jangka cendhak perusahaan TransCode Therapeutics (RNAZ)|bionanogenomics.com - Tanggungan utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan BLUE (bluebird bio)|IPA: Tanggungan utang jangka cendhak perusahaan|OMGA - Utang jangka cendhak perusahaan|OMIC (Singular Genomics Corp) - Tanggungan utang jangka cendhak perusahaan|RGLS: Utang jangka cendhak perusahaan|syros.com (SYRS) - Utang jangka cendhak perusahaan|TBIO (Telesis Bio) - Utang jangka cendhak perusahaan|Utang jangka cendhak perusahaan TRACON Pharmaceuticals Inc.|Utang jangka cendhak perusahaan Unity Bio (UBX)